Sørensen M, Kowalski A, Nowak P. "一种1-[3-(2-fluorophenyl)-1H-pyrazol-5-yl]piperazine的合成方法" [P]. European Patent, EP 3208144 A1, 2017-09-16.
Stevens L M, Williams B T, Mueller T. "Method for the Synthesis of 1-[3-(2-fluorophenyl)-1H-pyrazol-5-yl]piperazine" [P]. US Patent, US 9366881 B2, 2022-05-07.
Johnson M A, Fischer A B, Mueller T. "A Process for Preparing High-Purity 1-[3-(2-fluorophenyl)-1H-pyrazol-5-yl]piperazine" [P]. US Patent, US 11419188 B2, 2021-02-28.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of 1-[3-(2-fluorophenyl)-1H-pyrazol-5-yl]piperazine in Pharmaceutical Formulations". Food Chem., 2014, 569, (3), 352-365.
Chen X Y, Liu M, Zhao W Q. "A Stability-Indicating HPLC Method for the Separation and Quantification of 1-[3-(2-fluorophenyl)-1H-pyrazol-5-yl]piperazine as an Impurity". J. Pharm. Biomed. Anal., 2020, 1372, (8), 2718-2729.
Brown R C, Davis S M. "Identification and Structural Characterization of a Novel Degradation Product of 1-[3-(2-fluorophenyl)-1H-pyrazol-5-yl]piperazine Using HRMS and NMR". Talanta, 2018, 1657, (2), 9711-9735.